1. Home
  2. ACRV vs CRMT Comparison

ACRV vs CRMT Comparison

Compare ACRV & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • CRMT
  • Stock Information
  • Founded
  • ACRV 2018
  • CRMT 1981
  • Country
  • ACRV United States
  • CRMT United States
  • Employees
  • ACRV N/A
  • CRMT N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • CRMT Other Specialty Stores
  • Sector
  • ACRV Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • ACRV 247.8M
  • CRMT 270.3M
  • IPO Year
  • ACRV 2022
  • CRMT N/A
  • Fundamental
  • Price
  • ACRV $6.44
  • CRMT $43.07
  • Analyst Decision
  • ACRV Strong Buy
  • CRMT Hold
  • Analyst Count
  • ACRV 5
  • CRMT 3
  • Target Price
  • ACRV $22.40
  • CRMT $50.00
  • AVG Volume (30 Days)
  • ACRV 46.9K
  • CRMT 80.1K
  • Earning Date
  • ACRV 11-13-2024
  • CRMT 12-05-2024
  • Dividend Yield
  • ACRV N/A
  • CRMT N/A
  • EPS Growth
  • ACRV N/A
  • CRMT N/A
  • EPS
  • ACRV N/A
  • CRMT N/A
  • Revenue
  • ACRV N/A
  • CRMT $1,369,964,000.00
  • Revenue This Year
  • ACRV N/A
  • CRMT N/A
  • Revenue Next Year
  • ACRV N/A
  • CRMT $3.19
  • P/E Ratio
  • ACRV N/A
  • CRMT N/A
  • Revenue Growth
  • ACRV N/A
  • CRMT N/A
  • 52 Week Low
  • ACRV $3.19
  • CRMT $37.98
  • 52 Week High
  • ACRV $11.90
  • CRMT $83.07
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 31.95
  • CRMT 55.10
  • Support Level
  • ACRV $6.11
  • CRMT $40.80
  • Resistance Level
  • ACRV $8.35
  • CRMT $43.65
  • Average True Range (ATR)
  • ACRV 0.48
  • CRMT 1.37
  • MACD
  • ACRV -0.23
  • CRMT 0.32
  • Stochastic Oscillator
  • ACRV 12.55
  • CRMT 82.73

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It primarily sells older model used vehicles and provides financing for substantially all of its customers. The Company earns revenue from the sale of used vehicles and in most cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: